The availability of an oral GLP-1 with weight-lowering efficacy could potentially give people requiring treatment for obesity and their physicians a great option for choice of treatment. PIONEER PLUS compared three doses of oral semaglutide14 mg daily, 25 mg daily, or 50 mg dailyversus placebo in 1,606 individuals with type 2 diabetes
Researchers who understand both compounds mechanisms make better experimental design decisions and generate more impactful findings
Yes, for qualifying orders
Phase 2 clinical literature (Jastreboff et al., NEJM, 2023
C., Yu, Y
From that beginning, other researchers began looking for other ways in which the ulcer-healing compound, now called Body Protection Compound 157 (a marketing bonanza for those who would later promote it as a supplement), could be applied to sports injuries, ranging from muscle and tendon tears to cartilage damage, or even stress fractures and fully broken bones